Weston Nichols

Insider Reports History

Location
San Juan, PR
Signature
/s/ Tobin Schilke, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Weston Nichols:

Company Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. Director Common Stock 16,300 $543,116 $33.32 11 Jun 2025 Direct
Crinetics Pharmaceuticals, Inc. Director Stock Option (right to buy) 10,350 11 Jun 2025 Direct

Insider Reports Filed by Weston Nichols

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRNX Crinetics Pharmaceuticals, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 07 Jun 2024 2 $0 4 Director 11 Jun 2024, 16:20
CRNX Crinetics Pharmaceuticals, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 17:00
CRNX Crinetics Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 16:46
CRNX Crinetics Pharmaceuticals, Inc. 22 Jun 2021 1 $0 4 Director 23 Jun 2021, 17:00